Ziyang Shen

Ziyang Shen

Auto-generated profile, based on publicly available information

Ziyang Shen

Williams College, Williamstown, MA 01267, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
XYXia Yin
Xia Yin
JJJing Jin
Jing Jin
YSYaqin Sun
Yaqin Sun
XKXiaocen Kong
Xiaocen Kong
ZSZiyang Shen
Ziyang Shen
JMJianhua Ma
Jianhua Ma

18 October 2024 in Transfusion Medicine Reviews
Verified
Journal Article
Open access
JLJun Liu
Jun Liu
KPKevin Park
Kevin Park
ZSZiyang Shen
Ziyang Shen
YYYuhua Ye
Yuhua Ye
ELErnie Lee
Ernie Lee
LCLi Chai
Li Chai
B-thalassemia and sickle cell disease are among the most prevalent genetic blood disorders globally. These conditions arise from mutations in the B-globin gene, leading to defective hemoglobin production and resulting in anemia. Current treatments include y-globin inducers (eg, Hydroxyurea), blood transfusions, iron chelation therapy, and bone marrow transplantation. Recently approved disease-modifying agents and promising gene therapies offer hope, yet their broad application is constrained by scalability challenges. Traditionally, research and development for B-globinopathies have focused on y-globin induction. However, the s-globin variant, which is active during early embryonic development and subsequently silenced prenatally, was once considered noninducible by postnatal pharmacological means. Recent studies indicate that, akin to y-globin, enhancing s-globin expression could compensate for impaired B-globin synthesis, potentially ameliorating the clinical manifestations of B-globinopathies. This review critically examines the viability of s-globin induction as a therapeutic strategy for B-thalassemia and sickle cell diseases. It also delves into the burgeoning research on the mechanisms governing s-globin silencing and its pharmacological reactivation. We conclude with a discussion of prospective research directions and drug development initiatives aimed at exploiting s-globin's therapeutic promise. (c) 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

6 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
EJEthan Jeon
Ethan Jeon
ZSZiyang Shen
Ziyang Shen
SCSantiago Christ
Santiago Christ
EQEvelyn Qi
Evelyn Qi
IFIda Fan
Ida Fan
BTB W Thuronyi
B W Thuronyi
Custom DNA constructs have never been more common or important in the life sciences. Many researchers therefore devote substantial time and effort to molecular cloning, aided by abundant computer-aided design tools. However, support for managing and documenting the construction process, and for effectively handling and reducing the frequency of setbacks, is lacking. To address this need, we developed CloneCoordinate, a free, open-source electronic laboratory notebook specifically designed for cloning and fully implemented in Google Sheets. By maintaining a real-time, automatically prioritized task list, a uniform physical sample inventory, and standardized data structures, CloneCoordinate enables productive, collaborative cloning for individuals or teams. We demonstrate how the information captured by CloneCoordinate can be leveraged to troubleshoot assembly problems and provide data-driven insights into cloning efficiency. CloneCoordinate offers a new and uniquely accessible model for how to carry out, and iteratively improve on, real-world DNA assembly.

26 September 2022 in arXiv
Verified
Preprint
Open access
PDF file
CFChaoming Fang
Chaoming Fang
ZSZiyang Shen
Ziyang Shen
FTFengshi Tian
Fengshi Tian
Jie YangJie Yang
Jie Yang
Mohamad SawanMohamad Sawan
Mohamad Sawan
Real-time biosignal processing on wearable devices has attracted worldwide attention for its potential in healthcare applications. However, the requirement of low-area, low-power and high adaptability to different patients challenge conventional algorithms and hardware platforms. In this design, a compact online learning neuromorphic hardware architecture with ultra-low power consumption designed explicitly for biosignal processing is proposed. A trace-based Spiking-Timing-Dependent-Plasticity (STDP) lgorithm is applied to realize hardware-friendly online learning of a single-layer excitatory-inhibitory spiking neural network. Several techniques, including event-driven architecture and a fully optimized iterative computation approach, are adopted to minimize the hardware utilization and power consumption for the hardware implementation of online learning. Experiment results show that the proposed design reaches the accuracy of 87.36% and 83% for the Mixed National Institute of Standards and Technology database (MNIST) and ECG classification. The hardware architecture is implemented on a Zynq-7020 FPGA. Implementation results show that the Look-Up Table (LUT) and Flip Flops (FF) utilization reduced by 14.87 and 7.34 times, respectively, and the power consumption reduced by 21.69% compared to state of the art.